Skip to content
← Back to this collection

PUBLICATIONS · 22858507

Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Bone Marrow Transplant
Publication date
2013 Mar
First author
Sanchez-Garcia J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sanchez-Garcia J
      type
      Author
    2. name
      Serrano J
      type
      Author
    3. name
      Serrano-Lopez J
      type
      Author
    4. name
      Gomez-Garcia P
      type
      Author
    5. name
      Martinez F
      type
      Author
    6. name
      Garcia-Castellano JM
      type
      Author
    7. name
      Rojas R
      type
      Author
    8. name
      Martin C
      type
      Author
    9. name
      Rodriguez-Villa A
      type
      Author
    10. name
      Molina-Hurtado JR
      type
      Author
    11. name
      Alvarez MA
      type
      Author
    12. name
      Casaño J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sanchez-Garcia J
      type
      Author
    2. name
      Serrano J
      type
      Author
    3. name
      Serrano-Lopez J
      type
      Author
    4. name
      Gomez-Garcia P
      type
      Author
    5. name
      Martinez F
      type
      Author
    6. name
      Garcia-Castellano JM
      type
      Author
    7. name
      Rojas R
      type
      Author
    8. name
      Martin C
      type
      Author
    9. name
      Rodriguez-Villa A
      type
      Author
    10. name
      Molina-Hurtado JR
      type
      Author
    11. name
      Alvarez MA
      type
      Author
    12. name
      Casaño J
      type
      Author
    bibliography ids
    1. nci-bib-0691dd924ab025e4b74f6895
    book metadata
    content sha256
    c72034344db34803eeaa614c195bcede433a3b900ecfa3b9c4c53e6dd3907c03
    document type
    citation
    dois
    1. 10.1038/bmt.2012.147
    electronic publication date
    display
    2012 Jul 30
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22858507
    immutable id
    pubmed:22858507@c72034344db34803eeaa614c195bcede433a3b900ecfa3b9c4c53e6dd3907c03
    journal
    abbreviation
    Bone Marrow Transplant
    issn electronic
    1476-5365
    issn print
    0268-3369
    issue
    3
    name
    Bone marrow transplantation
    nlm unique id
    8702459
    pages
    396-402
    volume
    48
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22858507
      provenance
      batch id
      1e3045de9f47a5ccd566
      provider
      NCBI PubMed ESummary
      record sha256
      06b21d7ebb5e2278d9916996289bcbc5be5c10f1b2d780e5ff95f2176fe07d23
      response sha256
      0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
      retrieved at
      2026-09-09T23:46:50.128287+00:00
      publication date
      display
      2013 Mar
      precision
      month
      year
      2013
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22858507/
      title
      Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL.

      Preserved source evidence · Not medical advice